335 related articles for article (PubMed ID: 11375993)
1. Osteopontin, a novel substrate for matrix metalloproteinase-3 (stromelysin-1) and matrix metalloproteinase-7 (matrilysin).
Agnihotri R; Crawford HC; Haro H; Matrisian LM; Havrda MC; Liaw L
J Biol Chem; 2001 Jul; 276(30):28261-7. PubMed ID: 11375993
[TBL] [Abstract][Full Text] [Related]
2. A novel cryptic binding motif, LRSKSRSFQVSDEQY, in the C-terminal fragment of MMP-3/7-cleaved osteopontin as a novel ligand for α9β1 integrin is involved in the anti-type II collagen antibody-induced arthritis.
Kon S; Nakayama Y; Matsumoto N; Ito K; Kanayama M; Kimura C; Kouro H; Ashitomi D; Matsuda T; Uede T
PLoS One; 2014; 9(12):e116210. PubMed ID: 25545242
[TBL] [Abstract][Full Text] [Related]
3. Expression and characterization of recombinant osteopontin peptides representing matrix metalloproteinase proteolytic fragments.
Gao YA; Agnihotri R; Vary CP; Liaw L
Matrix Biol; 2004 Nov; 23(7):457-66. PubMed ID: 15579312
[TBL] [Abstract][Full Text] [Related]
4. The differential amino acid requirement within osteopontin in alpha4 and alpha9 integrin-mediated cell binding and migration.
Ito K; Kon S; Nakayama Y; Kurotaki D; Saito Y; Kanayama M; Kimura C; Diao H; Morimoto J; Matsui Y; Uede T
Matrix Biol; 2009 Jan; 28(1):11-9. PubMed ID: 19000758
[TBL] [Abstract][Full Text] [Related]
5. Characterization of stromelysin 1 (MMP-3), matrilysin (MMP-7), and membrane type 1 matrix metalloproteinase (MT1-MMP) derived fibrin(ogen) fragments D-dimer and D-like monomer: NH2-terminal sequences of late-stage digest fragments.
Bini A; Wu D; Schnuer J; Kudryk BJ
Biochemistry; 1999 Oct; 38(42):13928-36. PubMed ID: 10529239
[TBL] [Abstract][Full Text] [Related]
6. Distinct structural requirements for binding of the integrins alphavbeta6, alphavbeta3, alphavbeta5, alpha5beta1 and alpha9beta1 to osteopontin.
Yokosaki Y; Tanaka K; Higashikawa F; Yamashita K; Eboshida A
Matrix Biol; 2005 Sep; 24(6):418-27. PubMed ID: 16005200
[TBL] [Abstract][Full Text] [Related]
7. Osteopontin is cleaved at multiple sites close to its integrin-binding motifs in milk and is a novel substrate for plasmin and cathepsin D.
Christensen B; Schack L; Kläning E; Sørensen ES
J Biol Chem; 2010 Mar; 285(11):7929-37. PubMed ID: 20071328
[TBL] [Abstract][Full Text] [Related]
8. Osteopontin stimulates tumor growth and activation of promatrix metalloproteinase-2 through nuclear factor-kappa B-mediated induction of membrane type 1 matrix metalloproteinase in murine melanoma cells.
Philip S; Bulbule A; Kundu GC
J Biol Chem; 2001 Nov; 276(48):44926-35. PubMed ID: 11564733
[TBL] [Abstract][Full Text] [Related]
9. Adhesive properties of osteopontin: regulation by a naturally occurring thrombin-cleavage in close proximity to the GRGDS cell-binding domain.
Senger DR; Perruzzi CA; Papadopoulos-Sergiou A; Van de Water L
Mol Biol Cell; 1994 May; 5(5):565-74. PubMed ID: 7522656
[TBL] [Abstract][Full Text] [Related]
10. Nuclear factor-inducing kinase plays a crucial role in osteopontin-induced MAPK/IkappaBalpha kinase-dependent nuclear factor kappaB-mediated promatrix metalloproteinase-9 activation.
Rangaswami H; Bulbule A; Kundu GC
J Biol Chem; 2004 Sep; 279(37):38921-35. PubMed ID: 15247285
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo.
McQuibban GA; Gong JH; Wong JP; Wallace JL; Clark-Lewis I; Overall CM
Blood; 2002 Aug; 100(4):1160-7. PubMed ID: 12149192
[TBL] [Abstract][Full Text] [Related]
12. Selective cleavage of human IgG by the matrix metalloproteinases, matrilysin and stromelysin.
Gearing AJ; Thorpe SJ; Miller K; Mangan M; Varley PG; Dudgeon T; Ward G; Turner C; Thorpe R
Immunol Lett; 2002 Apr; 81(1):41-8. PubMed ID: 11841844
[TBL] [Abstract][Full Text] [Related]
13. Identification of dual alpha 4beta1 integrin binding sites within a 38 amino acid domain in the N-terminal thrombin fragment of human osteopontin.
Bayless KJ; Davis GE
J Biol Chem; 2001 Apr; 276(16):13483-9. PubMed ID: 11278897
[TBL] [Abstract][Full Text] [Related]
14. Osteopontin induces nuclear factor kappa B-mediated promatrix metalloproteinase-2 activation through I kappa B alpha /IKK signaling pathways, and curcumin (diferulolylmethane) down-regulates these pathways.
Philip S; Kundu GC
J Biol Chem; 2003 Apr; 278(16):14487-97. PubMed ID: 12473670
[TBL] [Abstract][Full Text] [Related]
15. Collagenase-1 (MMP-1), matrilysin-1 (MMP-7), and stromelysin-2 (MMP-10) are expressed by migrating enterocytes during intestinal wound healing.
Salmela MT; Pender SL; Karjalainen-Lindsberg ML; Puolakkainen P; Macdonald TT; Saarialho-Kere U
Scand J Gastroenterol; 2004 Nov; 39(11):1095-104. PubMed ID: 15545168
[TBL] [Abstract][Full Text] [Related]
16. Identification of novel matrix metalloproteinase-7 (matrilysin) cleavage sites in murine and human Fas ligand.
Vargo-Gogola T; Crawford HC; Fingleton B; Matrisian LM
Arch Biochem Biophys; 2002 Dec; 408(2):155-61. PubMed ID: 12464266
[TBL] [Abstract][Full Text] [Related]
17. JNK1 differentially regulates osteopontin-induced nuclear factor-inducing kinase/MEKK1-dependent activating protein-1-mediated promatrix metalloproteinase-9 activation.
Rangaswami H; Bulbule A; Kundu GC
J Biol Chem; 2005 May; 280(19):19381-92. PubMed ID: 15757900
[TBL] [Abstract][Full Text] [Related]
18. Degradation of tropoelastin by matrix metalloproteinases--cleavage site specificities and release of matrikines.
Heinz A; Jung MC; Duca L; Sippl W; Taddese S; Ihling C; Rusciani A; Jahreis G; Weiss AS; Neubert RH; Schmelzer CE
FEBS J; 2010 Apr; 277(8):1939-56. PubMed ID: 20345904
[TBL] [Abstract][Full Text] [Related]
19. Mapping of functional epitopes of osteopontin by monoclonal antibodies raised against defined internal sequences.
Kon S; Yokosaki Y; Maeda M; Segawa T; Horikoshi Y; Tsukagoshi H; Rashid MM; Morimoto J; Inobe M; Shijubo N; Chambers AF; Uede T
J Cell Biochem; 2002; 84(2):420-32. PubMed ID: 11787071
[TBL] [Abstract][Full Text] [Related]
20. Expressions of matrix metalloproteinase-9 (MMP-9), dentin sialophosphoprotein (DSPP), and osteopontin (OPN) at histologically negative surgical margins may predict recurrence of oral squamous cell carcinoma.
Ogbureke KU; Weinberger PM; Looney SW; Li L; Fisher LW
Oncotarget; 2012 Mar; 3(3):286-98. PubMed ID: 22410369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
